Lithium response and -116C/G polymorphism of XBP1 in Japanese patients with bipolar disorder [1]

International Journal of Neuropsychopharmacology

Volumn 8, Issue 4, 2005, Pages 631-632

  Kakiuchi, Chihiro ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID;

BIPOLAR DISORDER; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); ETHICS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LETTER; MEDICAL RECORD; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LITHIUM; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 25844482710     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146114570500533X     Document Type: Letter

References (9)

1. Del Zompo M, Ardau R, Palmas MA, Bocchetta A, Reina A, Piccardi MP (1999). Lithium response: association study with two candidate genes. Molecular Psychiatry 4 (Suppl.), S66-S67.
2. Gray NA, Zhou R, Du J, Moore GJ, Manji HK (2003). The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders. Journal of Clinical Psychiatry 64 (Suppl. 5), 3-17.
3. Ikeda A, Kato T (2003). Biological predictors of lithium response in bipolar disorder. Psychiatry and Clinical Neuroscience 57, 243-250.
4. Kakiuchi C, Ishiwata M, Umekage T, Tochigi M, Kohda K, Sasaki T, Kato T (2004). Association of the XBP1 116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry and Clinical Neuroscience 58, 438-440.
5. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, Tsujita T, Okazaki Y, Nanko S, Kunugi H, Sasaki T, Kato T (2003). Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics 35, 171-175.
6. 31P-MRS in bipolar disorder. International Journal of Neuropsychopharmacology 3, 83-85.
7. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E (1999). Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders. Journal of Psychiatric Research 33, 371-377.
8. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E (2001). Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics Journal 1, 71-77.
9. Steen VM, Lovlie R, Osher Y, Belmaker RH, Berle JO, Gulbrandsen AK (1998). The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 8, 259-268.